Viewing Study NCT03358004


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-03-29 @ 3:31 PM
Study NCT ID: NCT03358004
Status: TERMINATED
Last Update Posted: 2018-10-05
First Post: 2017-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
Sponsor: Mario Negri Institute for Pharmacological Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TNBC View
None metronomic chemotherapy View
None vinorelbine View
None capecitabine View